Hip / Knee Replacement Arthroplasty
Conditions
Interventions
None listed
Sponsors
Leids Universitair Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Participation in studies previously mentioned.
Exclusion criteria
Exclusion criteria: None.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Generic quality of life will be measured using the SF-36 and EQ-5D. Illness-specific quality of life after hip replacement will be measured using the Oxford Hip Score (OHS) and the Hip disability and Osteoarthritis Outcome Score (HOOS). Illness-specific quality of life after knee replacement will be measured using the Oxford Knee Score (OKS) en de Knee injury and Osteoarthritis Outcome Score (KOOS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Aseptic loosening will be determined by specific questions on readmissions and revision surgery, and a thorough review of the clinical charts. DNS polymorphisms will be selected in relevant candidate genes for the immune system or osteoarthritis. Genetic association analyses will be performed in a case-control design. | — |
Countries
Netherlands
Outcome results
None listed